Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)

SFOSF Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,468	8,186	8,686	12,603	17,924	19,268
Market Cap Growth	7.72%	-5.76%	-31.08%	-29.69%	-6.98%	106.13%
Enterprise Value	13,073	12,438	12,583	15,964	21,251	22,626
Last Close Price	1.96	1.80	2.19	3.21	4.38	4.66
PE Ratio	21.01	21.57	25.82	23.30	24.08	34.34
PS Ratio	1.52	1.46	1.49	1.98	2.92	4.15
PB Ratio	1.01	1.00	1.09	1.61	2.35	2.74
P/TBV Ratio	2.71	2.73	2.89	3.99	5.83	6.40
P/FCF Ratio	180.20	894.58	-	-	-	-
P/OCF Ratio	13.31	13.35	18.04	20.61	28.92	48.76
EV/Sales Ratio	2.33	2.21	2.15	2.51	3.46	4.87
EV/EBITDA Ratio	16.90	16.47	22.98	19.87	32.27	36.18
EV/EBIT Ratio	35.59	30.53	75.34	32.19	53.22	56.42
EV/FCF Ratio	278.19	1359.25	-	-	-	-
Debt / Equity Ratio	0.60	0.60	0.62	0.56	0.53	0.52
Debt / EBITDA Ratio	6.52	6.07	8.44	5.25	5.86	5.63
Debt / FCF Ratio	106.30	539.31	-	-	-	-
Asset Turnover	0.35	0.36	0.38	0.44	0.44	0.38
Inventory Turnover	3.01	2.90	3.01	3.77	3.82	3.03
Quick Ratio	0.72	0.68	0.73	0.78	0.75	0.71
Current Ratio	0.97	0.92	1.00	1.06	1.04	1.01
Return on Equity (ROE)	6.20%	6.03%	5.23%	7.70%	10.55%	9.25%
Return on Assets (ROA)	1.43%	1.61%	0.67%	2.13%	1.79%	2.05%
Return on Capital (ROIC)	1.74%	1.98%	0.84%	2.70%	2.21%	2.50%
Return on Capital Employed (ROCE)	3.20%	3.70%	1.50%	4.60%	4.00%	4.50%
Earnings Yield	4.76%	4.64%	3.87%	4.29%	4.15%	2.91%
FCF Yield	0.55%	0.11%	-3.12%	-1.92%	-0.91%	-1.48%
Dividend Yield	-	2.44%	1.74%	1.89%	2.02%	1.41%
Payout Ratio	69.40%	74.35%	102.89%	63.64%	40.48%	50.09%
Buyback Yield / Dilution	-0.04%	-0.02%	-2.40%	-1.74%	-	-
Total Shareholder Return	-	2.42%	-0.66%	0.16%	2.02%	1.41%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.